| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |